We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$585B
AUM Growth
+$29.3B
Cap. Flow
+$1.02B
Cap. Flow %
0.17%
Top 10 Hldgs %
17.95%
Holding
2,642
New
88
Increased
1,025
Reduced
900
Closed
73

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$2.03B
2
DD icon
DuPont de Nemours
DD
+$1.83B
3
CCI icon
Crown Castle
CCI
+$1.58B
4
MSFT icon
Microsoft
MSFT
+$1.48B
5
TRU icon
TransUnion
TRU
+$781M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.53%
3 Technology 15%
4 Consumer Discretionary 13.37%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ES icon
326
Eversource Energy
ES
$26.8B
$360M 0.06%
5,951,254
+405,845
+7% +$25M
IDXX icon
327
Idexx Laboratories
IDXX
$46.2B
$358M 0.06%
2,299,667
-104,092
-4% -$16.5M
CL icon
328
Colgate-Palmolive
CL
$73.6B
$356M 0.06%
4,880,620
-2,097,048
-30% -$151M
ROL icon
329
Rollins
ROL
$17.8B
$353M 0.06%
17,228,891
+108,418
+0.6% +$2.09M
PRTA icon
330
Prothena Corp
PRTA
$473M
$353M 0.06%
5,448,891
+1,026,626
+23% +$62.9M
WAB icon
331
Wabtec
WAB
$50.3B
$350M 0.06%
4,617,643
-111,851
-2% -$8.61M
JBTM
332
JBT Marel
JBTM
$6.32B
$349M 0.06%
3,452,180
+131,077
+4% +$12.1M
PSMT icon
333
Pricesmart
PSMT
$5.33B
$348M 0.06%
3,899,533
-344,398
-8% -$28.9M
NOC icon
334
Northrop Grumman
NOC
$81.8B
$348M 0.06%
1,208,892
+2,607
+0.2% +$702K
REGN icon
335
Regeneron Pharmaceuticals
REGN
$82.1B
$345M 0.06%
771,730
-47,176
-6% -$22.4M
OGS icon
336
ONE Gas
OGS
$5B
$343M 0.06%
4,651,609
+146,691
+3% +$10.8M
ONCE
337
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$341M 0.06%
3,822,959
+650,561
+21% +$49.4M
GRUB
338
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$339M 0.06%
3,215,272
-1,037,399
-24% -$106M
TTC icon
339
Toro Company
TTC
$9.41B
$338M 0.06%
5,444,304
-1,079,876
-17% -$72.4M
SPGI icon
340
S&P Global
SPGI
$120B
$338M 0.06%
2,159,707
+292,805
+16% +$44.5M
TDY icon
341
Teledyne Technologies
TDY
$31.6B
$337M 0.06%
2,115,710
+46,967
+2% +$6.82M
TFCFA
342
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$333M 0.06%
12,641,072
-563,350
-4% -$15.5M
MO icon
343
Altria Group
MO
$109B
$333M 0.06%
5,247,465
-5,649,623
-52% -$377M
CDK
344
DELISTED
CDK Global, Inc.
CDK
$332M 0.06%
5,268,110
+5,185,322
+6,263% +$327M
SIVB
345
DELISTED
SVB Financial Group
SIVB
$329M 0.06%
1,757,718
-407,836
-19% -$71.7M
PSB
346
DELISTED
PS Business Parks, Inc.
PSB
$327M 0.06%
2,446,813
-2,319
-0.1% -$308K
RBC icon
347
RBC Bearings
RBC
$17.5B
$326M 0.06%
2,603,853
-292,342
-10% -$31.8M
BSMX
348
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$322M 0.05%
31,872,890
-3,604,653
-10% -$37M
DGI
349
DELISTED
DigitalGlobe Inc.
DGI
$319M 0.05%
9,045,084
+144,160
+2% +$4.93M
COST icon
350
Costco
COST
$419B
$317M 0.05%
1,928,437
-129,430
-6% -$20.3M

Similar funds

T. Rowe Price Associates's Q3 2017 Portfolio in Review

As of Q3 2017, T. Rowe Price Associates held 2,642 positions worth $585B, up 5.3% from $556B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

T. Rowe Price Associates's Q3 2017 filing shows 88 new, 1,025 increased, 900 reduced and 73 closed positions. Its largest new stake was Brighthouse Financial: 4,532,679 shares worth $276M. The largest sale was Du Pont De Nemours E I, an estimated $1.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Financials and Technology.

  • T. Rowe Price Associates's largest Q3 2017 buy was Brighthouse Financial: 4,532,679 shares worth $276M.
  • T. Rowe Price Associates added most to Gen Digital in Q3 2017, an estimated $2.03B increase.
  • T. Rowe Price Associates's biggest Q3 2017 reduction was Starbucks, cutting an estimated $1.59B.
  • T. Rowe Price Associates fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $1.72B.
  • T. Rowe Price Associates's ten largest holdings make up 18% of its $585B portfolio in Q3 2017.
  • T. Rowe Price Associates opened 88 new positions and closed 73 in Q3 2017.
  • T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $585B.

Based on T. Rowe Price Associates's 13F filing for Q3 2017, filed 14 Nov 2017.